Importancia del tamaño de las tuberosidades en las complicaciones del complejo esclerosis tuberosa / Significance of tuber size for complications of tuberous sclerosis complex

Introducción: El complejo esclerosis tuberosa (CET) es uno de los trastornos neurocutáneos más frecuentes. Las tuberosidades corticales son las alteraciones patológicas más frecuentes y están relacionadas directamente con las principales expresiones clínicas, crisis epilépticas, retraso mental y comportamiento autista. El motivo de este trabajo es mostrar la importancia de los diferentes tipos de tuberosidades en la expresión clínica de los pacientes. Objetivo: La finalidad de este trabajo es relacionar el tamaño de las tuberosidades con la severidad de las alteraciones clínicas. Material y métodos: Se estudiaron retrospectivamente los hallazgos clínicos y neurorradiológicos de 45 pacientes infantiles (22 mujeres y 23 varones) con CET y comparamos los hallazgos clínicos con la localización, el tamaño y el número de las tuberosidades corticales en cada paciente. Resultados: Cuatro pacientes tenían tuberosidades muy voluminosas en los hemisferios cerebrales. Todas mostraban crisis epilépticas muy rebeldes y retraso mental profundo con comportamiento autista en 3 de ellos, pese a que se extirparon las tuberosidades en los 4 casos. Trece pacientes tenían tuberosidades de tamaño promedio-grande. Todos tenían crisis epilépticas muy rebeldes y retraso mental. Nueve pacientes habían tenido espasmos infantiles durante el primer año de vida y presentaban comportamiento autista. Veintiocho pacientes mostraban muchas tuberosidades de tamaño promedio-pequeño. La mayoría de ellos tenían crisis con buena respuesta al tratamiento farmacológico y poca prevalencia del autismo. Tres pacientes mostraban tuberosidad córtico-subcortical única en un polo frontal u occipital, todos ellos con crisis controladas con medicación y cociente intelectual normal. Trece pacientes de los 45 tenían tuberosidades cerebelosas, siempre asociadas a algún tipo de tuberosidad hemisférica y generalmente presentes en casos con mayor expresividad clínica. Conclusiones: Las tuberosidades de gran tamaño, aunque sean poco numerosas, tienen mucha mayor relación con la presencia de sintomatología clínica severa —crisis epilépticas, retraso mental y comportamiento autista— que las tuberosidades de pequeño-mediano tamaño, aunque sean muy numerosas (AU)

Introduction: Tuberous sclerosis complex (TSC) is one of the most frequent neurocutaneous disorders. Cortical tubers are the most common pathological changes in TSC and they are directly related to the disease's main clinical manifestations: seizures, mental retardation, and autistic behaviour. Objective: The aim of this study is to establish a correlation between tuber size and the severity of clinical features in TSC. Material and methods: We performed a retrospective study of the clinical and imaging findings from 45 TSC patients (22 females and 23 males) and compared the clinical features with the location, size, and number of the cortical tubers in each patient. Results: Four patients had voluminous tubers located in 1 or both cerebral hemispheres. All of these patients had intractable seizures and severe mental retardation; 3 of these cases also presented with autistic behaviour, despite tubers having been resected in all 4 patients. Thirteen patients had tubers of large-to-average size, and all patients in this group showed intractable seizures and mental retardation. Nine patients who had experienced infantile spasms during the first year of life presented autistic behaviour. Multiple tubers of small to average size were found in 28 patients. In general, this group had seizures that responded well to antiepileptic drugs and a low prevalence of autism. In 3 patients who all presented good seizure control and normal intelligence, single cortical/subcortical tubers were located in the frontal or occipital lobes. Of the total of 45 patients, 13 had cerebellar as well as cerebral tubers; these were generally present in cases with more severe clinical features. Conclusions: Although large tubers are less common than small to medium-sized ones, they are much more likely to be accompanied by severe clinical symptoms (seizures, mental retardation and autistic behaviour), even when the smaller tubers are quite numerous (AU)

Significance of tuber size for complications of tuberous sclerosis complex.

INTRODUCTION: Tuberous sclerosis complex (TSC) is one of the most frequent neurocutaneous disorders. Cortical tubers are the most common pathological changes in TSC and they are directly related to the disease's main clinical manifestations: seizures, mental retardation, and autistic behaviour. OBJECTIVE: The aim of this study is to establish a correlation between tuber size and the severity of clinical features in TSC. MATERIAL AND METHODS: We performed a retrospective study of the clinical and imaging findings from 45 TSC patients (22 females and 23 males) and compared the clinical features with the location, size, and number of the cortical tubers in each patient. RESULTS: Four patients had voluminous tubers located in 1 or both cerebral hemispheres. All of these patients had intractable seizures and severe mental retardation; 3 of these cases also presented with autistic behaviour, despite tubers having been resected in all 4 patients. Thirteen patients had tubers of large-to-average size, and all patients in this group showed intractable seizures and mental retardation. Nine patients who had experienced infantile spasms during the first year of life presented autistic behaviour. Multiple tubers of small to average size were found in 28 patients. In general, this group had seizures that responded well to antiepileptic drugs and a low prevalence of autism. In 3 patients who all presented good seizure control and normal intelligence, single cortical/subcortical tubers were located in the frontal or occipital lobes. Of the total of 45 patients, 13 had cerebellar as well as cerebral tubers; these were generally present in cases with more severe clinical features. CONCLUSIONS: Although large tubers are less common than small to medium-sized ones, they are much more likely to be accompanied by severe clinical symptoms (seizures, mental retardation and autistic behaviour), even when the smaller tubers are quite numerous.

Focal cortical dysplasia. Clinical-radiological-pathological associations.

INTRODUCTION: The term focal cortical dysplasia (FCD) describes a particular migration disorder with a symptomatology mainly characterised by drug-resistant epileptic seizures, typical neuroradiological images, and histological characteristics, as well as a very positive response to surgical treatment in the majority of cases. MATERIAL AND METHODS: A total of 7 patients were studied, comprising 6 children with a mean age of 34.3 months and one 25-year-old male with very persistent focal seizures and MRI images that showed FCD. RESULTS: Three of the patients (all girls) were operated on while very young, with extirpation of the FCD and the surrounding area; with the histopathology study showed agreement between the MRI images and the macroscopic study of the slices. The histology study showed findings typical of a Taylor-type FCD (poor differentiation between the cortical grey matter and the subcortical white matter, and balloon cells). Three years after the FCD extirpation, the same 3 patients remained seizure-free with no anti-epilepsy medication. Two others have seizure control with medication, another (the adult) is on the surgical waiting list, and the remaining patient refused the operation. CONCLUSION: Taylor-type FCD is associated with a high percentage of all drug-resistant focal seizures, and it needs to be identified and extirpated as soon as possible. Well planned and well-performed surgery that leaves no remains of dysplasia can cure the disease it in many cases.

[Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients]. / Astrocitoma subependimario de células gigantes en el complejo de esclerosis tuberosa. Presentación de ocho pacientes infantiles.

OBJECTIVE: Presentation of 8 patients with subependymal giant-cell astrocytomas (SGCA) associated with tuberous sclerosis complex (TSC). MATERIAL AND METHODS: There are 8 patients, 6 males and 2 females with TSC, who presented with the tumour between the neonatal period and 24 years. RESULTS: All patients showed bilateral hypersignalised areas in zones close to the foramen of Monro. Three of the patients were admitted urgently due to blindness and increased intracranial pressure. Incomplete removal of the tumour has always been bad solution as it resulted in the death of the patient (in one case) or further surgery operation in the short term. Only one patient developed the tumour suddenly from pre-existing subependymal nodules from the childhood and they had to be removed at 24 years of age. By contrast, 32 patients with TSC and images of subependymal nodules whose CT or MR progress was followed up for between 10 and 30 years did not develop a tumour. One patient had to be operated four times over 20 years. CONCLUSIONS: SGCA associated with TSC is a severe complication which as likely to develop and careful monitoring is required from neonatal age with periodicclinical and imaging studies in order to avoid its irreversible complications. Hydrocephaly, blindness and even the death can be the main consequences. Reintervention of the recurrent tumour is often necessary.

Astrocitoma subependimario de células gigantes en el complejo de esclerosis tuberosa. Presentación de ocho pacientes infantiles / Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients

Objetivo: Presentar 8 pacientes con astrocitomas subependimarios de células gigantes (ASGC) en relación con el complejo de esclerosis tuberosa (CET). Material y métodos: Ocho pacientes, 6 varones y 2 mujeres, con CET, que desarrollaron el tumor entre la etapa neonatal y los 24 años.Resultados: Todos mostraban áreas localizadas bilaterales de hiperseñal, en zonas próximas a los foramina de Monro. Tres ingresaron urgentemente con ceguera e hipertensión intracraneal. La extirpación parcial del tumor fue siempre una mala solución ya que acabó en reintervenciones a corto, medio o largo plazo o en la muerte de un paciente. Sólo en un caso vimos desarrollarse el tumor desde las zonas de hiperseñal subependimaria a partir de la preadolescencia para acabar en extirpación a los 24 años, mientras que 32 pacientes a los que se siguió la evolución de estas zonas de hiperseñal entre 10 y 30 años no desarrollaron tumor. Un paciente tuvo que ser operado cuatro veces a lo largo de 20 años por recidiva del tumor; se extirpó otro ASGC en el lado contralateral al mismo tiempo de la cuatra intervención en el lado del tumor primitivo. Otros 2 pacientes también mostraron recidiva y tuvieron que ser reintervenidos del tumor.Conclusiones: El ASGC en relación con CET es una complicación grave cuya posibilidad de desarrollo hay que controlar cuidadosamente desde la época neonatal, con estudios periódicos clínicos y de imagen, para evitar sus complicaciones irreversibles. La hidrocefalia, la ceguera e incluso la muerte pueden ser sus consecuencias. La reintervención de tumores recidivados a menudo es necesaria (AU)

Objective: Presentation of 8 patients with subependymal giant-cell astrocytomas (SGCA) associated with tuberous sclerosis complex (TSC).Material and methods: There are 8 patients, 6 males and 2 females with TSC, who presented with the tumour between the neonatal period and 24 years. Results: All patients showed bilateral hypersignalised areas in zones close to the foramen of Monro. Three of the patients were admitted urgently due to blindness and increased intracranial pressure. Incomplete removal of the tumour has always been bad solution as it resulted in the death of the patient (in one case) or further surgery operation in the short term. Only one patient developed the tumour suddenly from pre-existing subependymal nodules from the childhood and they had to be removed at 24 years of age. By contrast, 32 patients with TSC and images of subependymal nodules whose CT or MR progress was followed up for between 10 and 30 years did not develop a tumour. One patient had to be operated four times over 20 years.Conclusions: SGCA associated with TSC is a severe complication which as likely to develop and careful monitoring is required from neonatal age with periodicclinical and imaging studies in order to avoid its irreversible complications. Hydrocephaly, blindness and even the death can be the main consequences. Reintervention of the recurrent tumour is often necessary (AU)

[Opsoclonus-myoclonus-ataxia syndrome: two anatomo-clinical case reports]. / Sindrome opsoclono-mioclono-ataxia: dos casos anatomoclinicos.

INTRODUCTION: Opsoclonus-myoclonus-ataxia syndrome (OMAS) is characterised by the acute or subacute development of chaotic eye movements and diffuse myoclonus. On some occasions it is associated with ataxia and encephalopathy. In adults there are multiple causations and a possible paraneoplastic origin must always be taken into account. CASE REPORTS: We report two cases of OMAS of a paraneoplastic origin with a post mortem study. In the first case, the syndrome was associated to a small-cell carcinoma in the lungs, and in the second patient it was associated to a digestive lymphoma. Neuroimaging studies did not reveal any kind of alterations in either of the two cases. In our cases, none of the antibodies that are relatively frequently associated to this syndrome were found. In both of them, an immunomodulator treatment regimen was established; only the patient with the lymphoma showed an initial improvement with antineoplastic therapy. In the pathological study, alterations were observed in the brain stem, and in the second patient alterations were also found in the cerebellum. CONCLUSIONS: This is a rare condition that obliges the specialist to think in order to reach a correct diagnosis, and to search for the primary tumour and establish early treatment in order to bring about an improvement and even the remission of the neurological signs and symptoms. The pathological findings are not pathognomonic, but they are typical of this syndrome.

Síndrome opsoclono-mioclono-ataxia: dos casos anatomoclínicos / Opspclonus. Myoclonuz-ataxia syndrome: Two anatomo-clinical case reports

Introducción. El síndrome opsoclono-mioclono-ataxia (SOMA) se caracteriza por el desarrollo agudo o subagudode movimientos oculares caóticos y mioclono difuso. En algunas ocasiones, asocia ataxia y encefalopatía. En el adulto existen múltiples etiologías, y hay que tener siempre en cuenta el posible origen paraneoplásico. Casos clínicos. Presentamos dos casos de SOMA de origen paraneoplásico con estudio post mortem. En el primer caso, el síndrome se asoció a un carcinomade células pequeñas de pulmón, y en el segundo paciente a un linfoma digestivo. Los estudios de neuroimagen no mostraron alteraciones en ninguno de los dos casos. No se descubrió en nuestros casos ninguno de los anticuerpos asociados con relativa frecuencia a este síndrome. En ambos se pautó tratamiento inmunomodulador; únicamente el paciente con linfoma mejoró inicialmente con el tratamiento antineoplásico. En el estudio anatomopatológico se observaron alteraciones en el tronco del encéfalo, y en el segundo paciente también en el cerebelo. Conclusión. Se trata de una entidad rara, en la que hay que pensar para lograr un diagnóstico correcto, búsqueda del tumor primario y su tratamiento precoz, con el fin de producir mejoría e inclusoremisión del cuadro neurológico. Los hallazgos anatomopatológicos no son patognomónicos, pero sí típicos de este síndrome

Introduction. Opsoclonus-myoclonus-ataxia syndrome (OMAS) is characterised by the acute or subacute development of chaotic eye movements and diffuse myoclonus. On some occasions it is associated with ataxia and encephalopathy. In adults there are multiple causations and a possible paraneoplastic origin must always be taken into account. Case reports. Wereport two cases of OMAS of a paraneoplastic origin with a post mortem study. In the first case, the syndrome was associated to a small-cell carcinoma in the lungs, and in the second patient it was associated to a digestive lymphoma. Neuroimaging studies did not reveal any kind of alterations in either of the two cases. In our cases, none of the antibodies that are relativelyfrequently associated to this syndrome were found. In both of them, an immunomodulator treatment regimen was established; only the patient with the lymphoma showed an initial improvement with antineoplastic therapy. In the pathological study, alterations were observed in the brain stem, and in the second patient alterations were also found in the cerebellum. Conclusions. This is a rare condition that obliges the specialist to think in order to reach a correct diagnosis, and to search forthe primary tumour and establish early treatment in order to bring about an improvement and even the remission of the neurological signs and symptoms. The pathological findings are not pathognomonic, but they are typical of this syndrome

[Solitary fibrous tumors of the meninges: report of three cases and literature review]. / Tumor fibroso solitario meníngeo: descripción de tres casos y revisión de la literatura.

We report 3 patients with fibrous solitary tumor of meningeal location where we described the histological study, as well as evolution after the surgical treatment. The described patients presented ages of 37, 52 and 65 years, after the resection has not appeared an objective sign of recurrence in any case after 4, 6 and 7 years of follow-up respectively. Checking the literature the tumor is indistinguishable clinical and radiolocally of the typical meningioma, doing necessary the use of inmunohistochemistry to do the differential diagnosis, where positiveness for CD34 and the negativeness for EMA define the fibrous solitary tumor. It is about a benign tumor, where total removing is the principal factor in prognosis, nevertheless there are cases of local recurrences and long-distance metastasis. We can find all these characteristics in the showed cases of the present article, having the uncertainty of its local or systemic relapse ability in the future.

Tumor fibroso solitario meníngeo: descripción de tres casos y revisión de la literatura / Solitary fibrous tumors of the meninges: report of three cases and literature review

Presentamos 3 pacientes con tumor fibroso solitario de localización meníngea donde describimos el estudio histológico, así como la evolución después del tratamiento quirúrgico. Los pacientes descritos tenían edades de 37, 52 y 65 años y tras la resección total no se ha objetivado signo de recidiva en ningún caso después de 4, 6 y 7 años de seguimiento respectivamente. Revisando la literatura se trata de un tumor indistinguible clínica y radiológicamente del meningioma típico, haciendo necesario el uso de pruebas inmunohistoquímicas para realizar el diagnóstico diferencial, donde la positividad para el CD34 y la negatividad para el EMA definen al tumor fibroso solitario. Se trata de un tumor benigno, en el que la resección total es el principal factor pronóstico; no obstante, se han descrito casos de recidivas locales y metástasis a distancia. Todas estas características las encontramos en los casos presentados en el presente trabajo, quedando la incertidumbre de su capacidad de recidiva local o sistémica en el futuro

We report 3 patients with fibrous solitary tumor of meningeal location where we described the histological study, as well as evolution after the surgical treatment.The described patients presented ages of 37, 52 and 65years, after the resection has not appeared an objective sign of recurrence in any case after 4, 6 and 7 years of follow-up respectively. Checking the literature the tumor is indistinguishable clinical and radiolocally of the typical meningioma, doing necessary the use of inmunohistochemistry todo the differential diagnosis, where positiveness forCD34 and the negativeness for EMA define the fibrous solitary tumor. It is about a benign tumor, where total removing is the principal factor in prognosis, nevertheless there are cases of local recurrences and long-distance metastasis. We can find all these characteristics in the showed cases of the present article, having the uncertainty of its local or systemic relapse ability in the future

[Cerebellar ataxia of Norman-Jaeken. Presentation of seven Spanish patients]. / Ataxia cerebelosa de Norman-Jaeken. Presentación de siete pacientes españoles.

AIM: To show that the cerebellar ataxias described by Norman and by Jaeken (CDG1a) are the same disease. PATIENTS AND METHODS: Seven patients, five females and two males (there were two siblings pairs), who presented a severe cerebellar disease slowly progressive associated with generalized cerebellar atrophy. The sister of one of the patients of the series had been studied because of psychomotor retardation but she died at two years of age due to respiratory problems. An autopsy was carried out that showed severe cerebellar atrophy, and the histological study revealed loss of granular cells and diverse abnormalities of Purkinje's cells, especially focal swellings of 'asteroid bodies' or 'cactus like' type. This suggested to us that Norman's ataxia and CDG1a could be the same pathological entity. RESULTS: All seven patients had severe cerebellar hypoplasia-atrophy and a small brainstem. Most patients showed peripheral neuropathy with decreased motor nerve conduction velocity, but very little decreased sensory nerve conduction velocity. All seven patients had highly raised serum concentrations of asialotransferrin, and heterozygous molecular PMM2 deficit (CDG1a). One of these seven cases was the patient whose sister had histological cerebellar changes corresponding to Norman's ataxia. CONCLUSION: The findings observed in our series suggest that the diseases described by Norman and Jaeken are the same pathological entity and CDG1a can be the biological basis of the histological changes of the cerebellum in Norman's ataxia. We suggest the name of Norman-Jaeken ataxia or disease for this entity.

Ataxia cerebelosa de Norman-Jaeken. Presentación de siete pacientes españoles / Cerebellar ataxia of norman-jaeken. Presentation of seven spanish patients

Objetivo. Mostrar que las ataxias cerebelosas descritas por Norman y por Jaeken (CDG1a) son el mismo trastorno. Pacientes y métodos. Siete pacientes, cinco mujeres y dos varones (había dos pares de hermanos), que presentaban una ataxia aguda lentamente progresiva asociada con atrofia cerebelosa generalizada. La hermana de uno de los pacientes de esta serie había sido objeto de estudio por un retraso psicomotor, pero murió a los dos años de edad debido a problemas respiratorios. La autopsia mostraba atrofia cerebelosa aguda, y el estudio histológico revelaba pérdida de la capa de los granos y diversas anormalidades de las células de Purkinje, especialmente inflamación focal de tipo ‘cuerpos asteroides' o cactus-like. Esto nos hizo pensar que la ataxia de Norman y laCDG1a podrían ser la misma entidad patológica. Resultados. Los siete pacientes tenían hipoplasia-atrofia aguda y disminución del grosor del tronco cerebral. La mayoría de los pacientes mostraba una neuropatía periférica con reducción de la velocidad de conducción motora, pero con muy poca disminución de la conducción sensitiva. Los siete pacientes tenían aumentados los niveles séricos deasia lotransferrina, y presentaban una deficiencia molecular heterocigótica PMM2 (CDG1a). Uno de estos siete casos era el paciente cuya hermana tenía cambios histológicos cerebelosos correspondientes a la ataxia de Norman. Conclusiones. Los hechos clínicos y de imagen de los pacientes de nuestra serie, a los que se les había diagnosticado la enfermedad de Norman, son similares a los descritos en los pacientes con síndrome de Jaeken. Ello nos hace pensar que ambas enfermedades son una misma entidad patológica. Los hallazgos obtenidos en nuestra serie indican que la CDG1a es la base bioquímica de los cambios histológicos en el cerebelo en los casos de ataxia de Norman (AU)

Aim. To show that the cerebellar ataxias described by Norman and by Jaeken (CDG1a) are the same disease. Patients and methods. Seven patients, five females and two males (there were two siblings pairs), who presented a severe cerebellar disease slowly progressive associated with generalized cerebellar atrophy. The sister of one of the patients of the series had been studied because of psychomotor retardation but she died at two years of age due to respiratory problems. An autopsy was carried out that showed severe cerebellar atrophy, and the histological study revealed loss of granular cells and diverse abnormalities of Purkinje’s cells, especially focal swellings of ‘asteroid bodies’ or ‘cactus like’ type. This suggested tous that Norman’s ataxia and CDG1a could be the same pathological entity. Results. All seven patients had severe cerebellar hypoplasia-atrophy and a small brainstem. Most patients showed peripheral neuropathy with decreased motor nerve conduction velocity, but very little decreased sensory nerve conduction velocity. All seven patients had highly raised serum concentrations of asial o transferrin, and heterozygous molecular PMM2 deficit (CDG1a). One of these seven cases was the patient whose sister had histological cerebellar changes corresponding to Norman’s ataxia. Conclusion. The findings observed in our series suggest that the diseases described by Norman and Jaeken are the same pathological entity and CDG1a can be the biological basis of the histological changes of the cerebellum in Norman’s ataxia. We suggest the name of Norman-Jaeken ataxia or disease for this entity (AU)

[Mitochondrial respiratory chain diseases. Evaluation and variability in 52 patients]. / Enfermedades de la cadena respiratoria mitocondrial. Evaluación y variabilidad en 52 pacientes.

INTRODUCTION: Clinical, electrophysiological, genetic and biochemical deficiencies variability were evaluated in 52 patients diagnosed of mitochondrial respiratory chain diseases (MRCD). PATIENTS AND METHODS: 26 men and 26 women, aged 19 to 79 years, were tested by clinical examination, electrophysiological techniques, muscle biopsy and genetic and biochemical studies. RESULTS: The patients were classified into seven phenotypes: myopathy, chronic progressive external ophthalmoplegia, progressive ophthalmoplegia plus ataxia, Kearns-Sayre syndrome, mitochondrial encephalomyopathy with lactic acidosis and stroke episodes (MELAS), myoclonic encephalopathy with ragged-red fibers (MERRF), and encephalopathies. Each phenotype may begin by different ways. The electromiography showed myopathy in 39 cases and various types of neuropathy in 10. Ragged-red COX negative fibers or widespread electron microscopic abnormalities were found in 47 cases. Simple deletions, multiple deletions and three different point mutations were observed. Deficiency of complexes I, II, III and IV were found alone or in different associations. CONCLUSIONS: MRCD shows wide variations in clinical, genetic and biochemical studies. Some patients with nonspecific manifestations, mainly of central nervous system, need careful attention and to be on account of diagnostic suspicion.

Enfermedades de la cadena respiratoria mitocondrial. Evaluación y variabilidad en 52 pacientes / Mitochondrial respiratory chain diseases. Evaluation and variability in 52 patients

Introducción. La variabilidad clínica, electrofisiológica, de las deficiencias bioquímicas y genéticas se evaluó en 52 pacientes diagnosticados de enfermedades de la cadena respiratoria mitocondrial (ECRM). Pacientes y métodos. Se evaluó a 26 hombres y 26 mujeres, de edades comprendidas entre 19 y 79 años, mediante exploración clínica, técnicas electrofisiológicas, biopsia de músculo y estudios bioquímico y genético. Resultados. Se clasificó a los pacientes en siete fenotipos: miopatía, oftalmoplejía externa progresiva crónica, oftalmoplejía progresiva plus con ataxia, síndrome de Kearns-Sayre, encefalomiopatía mitocondrial con acidosis láctica y episodios de ictus (MELAS), encefalopatía mioclónica con fibras rojo rasgadas (MERRF) y encefalopatía. Cada fenotipo puede debutar de forma diferente. La electromiografía mostró miopatía en 39 casos y diferentes tipos de neuropatía en 10. En 47 casos se puso de manifiesto la presencia de fibras rojo rasgadas COX negativas o alteraciones mitocondriales prominentes al microscopio electrónico. Se observaron deleciones simples y múltiples, así como tres mutaciones puntuales diferentes. Se encontraron deficiencias de los complejos I, II, III y IV aisladas o en diferentes asociaciones. Conclusiones. Las ECRM muestran grandes diferencias entre ellas en los estudios clínicos, bioquímicos y genéticos. Algunos pacientes con manifestaciones inespecíficas, principalmente del sistema nervioso central, requieren una atención cuidadosa y que se plantee la sospecha diagnóstica de ECRM (AU)

Introduction. Clinical, electrophysiological, genetic and biochemical deficiencies variability were evaluated in 52 patients diagnosed of mitochondrial respiratory chain diseases (MRCD). Patients and methods. 26 men and 26 women, aged 19 to 79 years, were tested by clinical examination, electrophysiological techniques, muscle biopsy and genetic and biochemical studies. Results. The patients were classified into seven phenotypes: myopathy, chronic progressive external ophthalmoplegia, progressive ophthalmoplegia plus ataxia, Kearns-Sayre syndrome, mitochondrial encephalomyopathy with lactic acidosis and stroke episodes (MELAS), myoclonic encephalopathy with ragged-red fibers (MERRF), and encephalopathies. Each phenotype may begin by different ways. The electromiography showed myopathy in 39 cases and various types of neuropathy in 10. Ragged-red COX negative fibers or widespread electron microscopic abnormalities were found in 47 cases. Simple deletions, multiple deletions and three different point mutations were observed. Deficiency of complexes I, II, III and IV were found alone or in different associations. Conclusions. MRCD shows wide variations in clinical, genetic and biochemical studies. Some patients with nonspecific manifestations, mainly of central nervous system, need careful attention and to be on account of diagnostic suspicion (AU)

ANCA-associated vasculitis as paraneoplastic syndrome with colon cancer: a case report.

Coexistence of a vasculitis and a neoplastic disease is rare and the pathogenesis is unknown. Most of these associations refer to leukocytoclastic or poliarteritis nodosa (PAN)-type vasculitis and hematological malignancies. There are few reports of vasculitis in patients with solid tumours and there are also few reports of paraneoplastic ANCA-associated vasculitis. We report a case of p-ANCA-positive vasculitis with peripheral nerve involvement associated with a colon cancer. Vasculitis resolved after corticoid treatment and surgical removal of the tumour.

[Muscle-eye-brain disease. Presentation of one case with genetic study]. / Trastorno músculo-ojo-cerebro. Presentación de un caso con estudio genético.

INTRODUCTION: The objective [corrected] is to present a case of muscle-eye-brain (MEB) disease with genetic study. MATERIAL AND METHODS: We studied an affected male from the age of 7 months to 21 years. During this time, clinical, analytical, neurophysiological (EEG, EMG, visual evoked potential [VEP], electroretinogram [ERG]), image (CT, MR), cerebral biopsy and genetic studies were performed. RESULTS: Severe visual acuity impairment with optic atrophy from the first months of life, abnormal VEP and ERG, CT and MR showing <> image of the cerebral cortex and subcortical white matter with myelinating changes; the histologic study of the cerebral biopsy sample showed hypomyelinating lesions and migration changes. The patient is alive at 21 years of age. The genetic study confirmed the presence of two recessive mutations, c.1274G>C and c.1895+1_4delGTGA, within the POMGnT1 gene. CONCLUSIONS: The patient shows typical clinical, neurophysiological, histological and genetic MEB features.

Trastorno músculo-ojo-cerebro. Presentación de un caso con estudio genético / Muscle-eye-brain disease. Presentation of one case with genetic study

Introducción. El objetivo es presentar un caso de trastorno músculo-ojo-cerebro con estudio genético. Material y métodos. Se ha estudiado un varón afecto desde los 7 meses hasta los 21 años y se le han practicado todos los estudios clínicos, analíticos, neurofisiológicos (EEG, EMG, potenciales evocados visuales [PEV] y electrorretinograma [ERG]), de imagen (TC, RM), biopsia cerebral y genéticos (secuenciacion de la región codificante y sitios de splicing del gen POMGnT1). Resultados. Afectación visual con atrofia papilar desde los primeros meses de vida, afectación severa de los PEV y del ERG, imágenes típicas de afectación cortical cerebral tipo cobblestone complex, de la sustancia blanca subcortical que afectaban a la mielinización en la TC y en la RM y lesiones hipomielínizantes y trastornos de la migración en el estudio histológico del tejido cerebral obtenido en la biopsia. El paciente sigue vivo. El estudio genético muestra la presencia de dos mutaciones recesivas, c.1274G > C y c.1895 + 1_4deIGTGA, en el gen POMGnT1. Conclusión. El paciente muestra todas las características clínicas, neurofisiológicas, de imagen, histológicas y genéticas del trastorno músculo-ojo-cerebro

Introduction. The objetive is to present a case of muscle-eye-brain (MEB) disease with genetic study. Material and methods. We studied an affected male from the age of 7 months to 21 years. During this time, clinical, analytical, neurophysiological (EEG, EMG, visual evoked potential [VEP], electroretinogram [ERG]), image (CT, MR), cerebral biopsy and genetic studies were performed. Results. Severe visual acuity impairment with optic atrophy from the first months of life, abnormal VEP and ERG, CT and MR showing «cobblestone complex» image of the cerebral cortex and subcortical white matter with myelinating changes; the histologic study ofthe cerebral biopsy sample showed hypomyelinating lesions and migration changes. The patient is alive at 21 years of age. The genetic study confirmed the presence of two recessive mutations, c.1274G > C and c.1895 + 1-4deIGTGA, within the POMGnT1 gene. Conclusions. The patient shows typical clinical, neurophysiological, histological and genetic MEB features

Vacuolating megalencephalic leukoencephalopathy: 24 year follow-up of two siblings.

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive disorder with a chronic progressive course. The gene, MLC1, has been localized on chromosome 22qtell and 26 different mutations have been described. We report two siblings of non-consanguineous parents who presented with characteristic features of MLC. They showed macrocephaly from the first months of life. After a short time, motor clumsiness, ataxia, seizures and psychomotor retardation were observed. During childhood, both patients had a coma that lasted several days following a minor head trauma. The eldest sister experienced a permanent deterioration of the clinical picture after the coma. Epilepsy and electroencephalographic alterations were chronic, tending to improve during adulthood. Cerebral biopsy showed normal or minor changes in the cortical grey matter, and in the white matter gliosis, increased extracellular spaces and decreased numbers of fibres with thin myelin sheets. We have followed the patients during 24 years, from the ages of 4 and 8 years to the their present ages of 28 and 32 years. Clinical and neuro-imaging follow-up showed a chronic course with more prominent progression of the white matter abnormalities than of the neurological features. A homozygous mutation of the MLC1 gene was found in both siblings. The eldest patient, 32 years-old, needs a wheel-chair but has a good contact with the family and surrounding people. The youngest, 28-years-old, shows mild ataxia, spasticity and motor clumsiness, but she is able to participate in activities of daily life.

Vacuolating megalencephalic leucoencephalopathy: 24 years follow-up of two siblings

La leucoencefalopatía megalencefálica con quistes subcorticales (MLC) es un trastorno de herencia autosómica recesiva de curso progresivo crónico. El gen MLC1 ha sido localizado en el cromosoma 22qtell y ya han sido descritas 26 mutaciones diferentes. Presentamos dos hermanas, hijas de padres no consanguíneos con las características propias de la MLC. Las dos mostraban macrocefalia desde los primeros meses de vida. Tras un corto tiempo se observó en ellas torpeza motora, ataxia, crisis y retraso psicomotor. Durante la niñez ambas presentaron estado de coma que duró algunos días tras un trauma craneal de poca importancia. La hermana mayor experimentó deterioro permanente del cuadro clínico durante la edad adulta. La epilepsia y las alteraciones en el electroencefalograma eran crónicas, tendiendo a mejorar en la edad adulta. La biopsia cerebral mostró normalidad o cambios menores en la sustancia gris cortical, mientras que en la sustancia blanca existía gliosis, aumento de los espacios extracelulares y disminución del número de fibras con finas vainas de mielina. Hemos seguido a las pacientes durante 24 años, desde que tenían 4 y 8 años, respectivamente, hasta la actualidad en que tienen 28 y 32 años. El seguimiento clínico y de neuroimagen mostró un curso crónico con progresión más acentuada de las anormalidades en la sustancia blanca que en la expresividad clínica. Se encontró en las dos hermanas una mutación homozigótica del gen MLC1. La hermana mayor, de 32 años, necesita silla de ruedas para moverse, pero contacta bien con la familia y la gente de su entorno. La joven, de 28 años, muestra una discreta ataxia, espasticidad y torpeza motora, pero puede participar en las actividades comunes de la vida diaria

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive disorder with a chronic progressive course. The gene, MLC1, has been localized on chromosome 22qtell and 26 different mutations have been described. We report two siblings of non-consanguineous parents who presented with characteristic features of MLC. They showed macrocephaly from the first months of life. After a short time, motor clumsiness, ataxia, seizures and psychomotor retardation were observed. During childhood, both patients had a coma that lasted several days following a minor head trauma. The eldest sister experienced a permanent deterioration of the clinical picture after the coma. Epilepsy and electroencephalographic alterations were chronic, tending to improve during adulthood. Cerebral biopsy showed normal or minor changes in the cortical grey matter, and in the white matter gliosis, increased extracellular spaces and decreased numbers of fibres with thin myelin sheets . We have followed the patients during 24 years, from the ages of 4 and 8 years to the their present ages of 28 and 32 years. Clinical and neuro-imaging follow-up showed a chronic course with more prominent progression of the white matter abnormalities than of the neurological features. A homozygous mutation of the MLC1 gene was found in both siblings. The eldest patient, 32 years-old, needs a wheel-chair but has a good contact with the family and surroundingpeople. The youngest, 28-years-old, shows mild ataxia, spasticity and motor clumsiness, but she is able to participate in activities of daily life

Single fiber electromyography (SFEMG) in mitochondrial diseases (MD).

Conventional EMG, nerve conduction studies and SFEMG were performed in 18 patients with various phenotypes of MD. 14 cases showed findings consistent with mild myopathy, 2 patients signs of sensory-motor axonal neuropathy and 2 cases a mixture of myopathy and axonal neuropathy. Motor unit fiber density was mild increased in 8 out of 13 tested cases. Jitter was abnormal in 10 out of 18 tested patients. Jitter abnormalities were not related to myopathic or neurogenic features in the EMG study, and may be observed in muscles without clinical weakness. The results suggest the existence of neuromuscular transmission disturbances in patients with MD.

Cerebellar hypoplasia with heterotopic purkinje cells in the molecular layer and preservation of the granule layers associated with severe encephalopathy. A new entity?

We present the case of an infant girl, born to first cousins, with a clinical phenotype consisting of microcephaly, hypotonia, strabismus and severe psychomotor retardation. Magnetic resonance imaging (MRI) showed global cerebellar atrophy involving the vermis and both hemispheres. The patient's serum transferrin levels were consistently unremarkable. Cerebellar biopsy, performed at 13 months of age, revealed heterotopic Purkinje cells in the molecular layer, but preservation of the external and internal granular layers. To our knowledge, this histological pattern of cerebellar cortical disorganization has not been described previously. The consanguinity of the parents suggests an autosomal recessive inheritance.